Part 3.1 / M1, M8, M11

Index-Nr.

►M18  Chemische Bezeichnung ◄

EG-Nr.

CAS-Nr.

Einstufung

Kennzeichnung

►M18  Spezifische Konzentrationsgrenzen, M-Faktoren und ATE (*1)  ◄

Anmerkungen

►M16   ►C14  Kodierung der Gefahrenklassen und -kategorien ◄  ◄

Kodierung der Gefahrenhinweise

Piktogramm, Kodierung der Signalworte

Kodierung der Gefahrenhinweise

Kodierung der ergänzenden Gefahrenmerkmale

▼M16

015-003-00-2

Calciumphosphid; Tricalciumdiphosphid

215-142-0

1305-99-3

Water-react. 1

Acute Tox. 2

Acute Tox. 3

Acute Tox. 1

Eye Dam. 1

Aquatic Acute 1

H260

H300

H311

H330

H318

H400

GHS02

GHS06

GHS05

GHS09

Dgr

H260

H300

H311

H330

H318

H400

EUH029

EUH032

M = 100

019-003-00-3

Kalium-(E,E)-hexa-2,4-dienoat

246-376-1

24634-61-5

Eye Irrit. 2

H319

GSH07

Wng

H319

031-001-00-4

Galliumarsenid

215-114-8

1303-00-0

Repr. 1B

Carc. 1B

STOT RE 1

H360F

H350

H372 (Atmungssystem und hämatopoetisches System)

GHS08

Dgr

H360F

H350

H372 (Atmungssystem und hämatopoetisches System)

050-008-00-3

Tributyl-Zinnverbindungen, soweit in diesem Anhang nicht gesondert aufgeführt

—

—

Repr. 1B

Acute Tox. 3

Acute Tox. 4*

STOT RE 1

Skin Irrit. 2

Eye Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H360FD

H301

H312

H372**

H315

H319

H400

H410

GHS08

GHS06

GHS09

Dgr

H360FD

H301

H312

H372**

H315

H319

H410

*

STOT RE 1; H372: C ≥ 1 %

STOT RE 2; H373: 0,25 % ≤ C < 1 %

Skin Irrit. 2; H315:C ≥ 1 %

Eye Irrit. 2; H319:C ≥ 1 %

M = 10

A

1

603-102-00-9

1,2-Epoxybutan

203-438-2

106-88-7

Flam. Liq. 2

Carc. 2

Acute Tox. 4*

Acute Tox. 4*

Acute Tox. 4*

STOT SE 3

Skin Irrit. 2

Eye Irrit. 2

H225

H351

H302

H312

H332

H335

H315

H319

GHS02

GHS08

GHS07

Dgr

H225

H351

H302

H312

H332

H335

H315

H319

603-197-00-7

Tebuconazol (ISO); 1-(4-Chlorphenyl)-4,4-dimethyl-3-(1,2,4-triazol-1-ylmethyl)pentan-3-ol

403-640-2

107534-96-3

Repr. 2

Acute Tox. 4

Aquatic Acute 1

Aquatic Chronic 1

H361d***

H302

H400

H410

GHS08

GHS07

GHS09

Wng

H361d***

H302

H410

M = 1

M = 10

606-054-00-7

Isoxaflutol (ISO); 5-Cyclopropyl-1,2-oxazol-4-yl α,α,α-trifluor-2-mesyl-p-tolyl keton

—

141112-29-0

Repr. 2

Aquatic Acute 1

Aquatic Chronic 1

H361d***

H400

H410

GHS08

GHS09

Wng

H361d***

H410

M = 10

M = 100

606-148-00-8

Carvon (ISO);

2-Methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-on; [1]

d-Carvon; (5S)-2-Methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-on; [2]

l-Carvon; (5R)-2-Methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-on [3]

202-759-5 [1]

218-827-2 [2]

229-352-5 [3]

99-49-0 [1]

2244-16-8 [2]

6485-40-1 [3]

Skin Sens. 1

H317

GHS07

Wng

H317

606-149-00-3

Tembotrion (ISO); 2-{2-Chlor-4-(methylsulfonyl)-3-[(2,2,2-trifluorethoxy)methyl]benzoyl}cyclohexan-1,3-dion

—

335104-84-2

Repr. 2

STOT RE 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H361d

H373 (Augen, Nieren, Leber)

H317

H400

H410

GHS08

GHS07

GHS09

Wng

H361d

H373 (Augen, Nieren, Leber)

H317

H410

M = 100

M = 10

607-197-00-8

Nonansäure

203-931-2

112-05-0

Skin Irrit. 2

Eye Irrit. 2

Aquatic Chronic 3

H315

H319

H412

GHS07

Wng

H315

H319

H412

607-707-00-9

Fenoxaprop-P-ethyl (ISO); Ethyl (2R)-2-{4-[(6-chlor-1,3-benzoxazol-2-yl)oxy]phenoxy}propanoat

—

71283-80-2

STOT RE 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H373 (Nieren)

H317

H400

H410

GHS08

GHS07

GHS09

Wng

H373 (Nieren)

H317

H410

M = 1

M = 1

607-708-00-4

Octansäure

204-677-5

124-07-2

Skin Corr. 1C

Aquatic Chronic 3

H314

H412

GHS05

Dgr

H314

H412

607-709-00-X

Decansäure

206-376-4

334-48-5

Skin Irrit. 2

Eye Irrit. 2

Aquatic Chronic 3

H315

H319

H412

GHS07

Wng

H315

H319

H412

607-710-00-5

1,2-Benzoldicarbonsäure, Dihexylester, verzweigt und linear

271-093-5

68515-50-4

Repr. 1B

H360FD

GHS08

Dgr

H360FD

607-711-00-0

Spirotetramat (ISO); (5s,8s)-3-(2,5-Dimethylphenyl)-8-methoxy-2-oxo-1-azaspiro[4,5]dec-3-en-4-ylethylcarbonat

—

203313-25-1

Repr. 2

STOT SE 3

Eye Irrit. 2

Skin Sens. 1A

Aquatic Acute 1

Aquatic Chronic 1

H361fd

H335

H319

H317

H400

H410

GHS08

GHS07

GHS09

Wng

H361fd

H335

H319

H317

H410

M = 1

M = 1

607-712-00-6

Dodemorphacetat; 4-Cyclododecyl-2,6-dimethylmorpholin-4-ium acetat

250-778-2

31717-87-0

Repr. 2

STOT RE 2

Skin Corr. 1C

Skin Sens. 1A

Aquatic Chronic 1

H361d

H373 (Leber)

H314

H317

H410

GHS08

GHS05

GHS07

GHS09

Dgr

H361d

H373 (Leber)

H314

H317

H410

EUH071

M = 1

607-713-00-1

Fenpyroximat (ISO); Tert-butyl 4-[({(E)-[(1,3-dimethyl-5-phenoxy-1H-pyrazol-4-yl)methylen]amino}oxy)methyl]benzoat

—

134098-61-6

Acute Tox. 3

Acute Tox. 2

Skin Sens. 1B

Aquatic Acute 1

Aquatic Chronic 1

H301

H330

H317

H400

H410

GHS06 GHS09

Dgr

H301

H330

H317

H410

M = 100

M = 1 000

607-714-00-7

Triflusulfuron-methyl; Methyl 2-({[4-(dimethylamino)-6-(2,2,2-trifluorethoxy)-1,3,5-triazin-2-yl]carbamoyl}sulfamoyl)-3-methylbenzoat

—

126535-15-7

Carc. 2

Aquatic Acute 1

Aquatic Chronic 1

H351

H400

H410

GHS08

GHS09

Wng

H351

H410

M = 100

M = 10

607-715-00-2

Bifenazat (ISO); Isopropyl 2-(4-methoxybiphenyl-3-yl)hydrazincarboxylat

442-820-5

149877-41-8

STOT RE 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H373

H317

H400

H410

GHS08

GHS07

GHS09

Wng

H373

H317

H410

M = 1

M = 1

613-042-00-5

Imazalil (ISO); 1-[2-(Allyloxy)-2-(2,4-dichlorphenyl)ethyl]-1H-imidazol

252-615-0

35554-44-0

Carc. 2

Acute Tox. 3

Acute Tox. 4

Eye Dam. 1

Aquatic Chronic 1

H351

H301

H332

H318

H410

GHS08

GHS06

GHS05

GHS09

Dgr

H351

H301

H332

H318

H410

M = 10

613-057-00-7

Dodemorph (ISO); 4-Cyclododecyl-2,6-dimethylmorpholin

216-474-9

1593-77-7

Repr. 2

STOT RE 2

Skin Corr. 1C

Skin Sens. 1A

Aquatic Acute 1

Aquatic Chronic 1

H361d

H373 (Leber)

H314

H317

H400

H410

GHS08

GHS05

GHS07

GHS09

Dgr

H361d

H373 (Leber)

H314

H317

H410

EUH071

M = 1

M = 1

613-133-00-X

Etridiazol (ISO); 5-Ethoxy-3-trichlormethyl-1,2,4-thiadiazol

219-991-8

2593-15-9

Carc. 2

Acute Tox. 4

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H351

H302

H317

H400

H410

GHS08

GHS07

GHS09

Wng

H351

H302

H317

H410

M = 1

M = 1

613-149-00-7

Pyridaben (ISO); 2-tert-Butyl-5-(4-tert-butylbenzylthio)-4-chlorpyridazin-3(2H)-on

405-700-3

96489-71-3

Acute Tox. 3

Acute Tox. 3

Aquatic Acute 1

Aquatic Chronic 1

H331

H301

H400

H410

GHS06

GHS09

Dgr

H331

H301

H410

M = 1 000

M = 1 000

613-319-00-0

Imidazol

206-019-2

288-32-4

Repr. 1B

Acute Tox. 4

Skin Corr. 1C

H360D

H302

H314

GHS08

GHS07

GHS05

Dgr

H360D

H302

H314

613-320-00-6

Lenacil (ISO); 3-Cyclohexyl-6,7-dihydro-1H-cyclopenta[d]pyrimidin-2,4(3H,5H)-dion

218-499-0

2164-08-1

Carc. 2

Aquatic Acute 1

Aquatic Chronic 1

H351

H400

H410

GHS08

GHS09

Wng

H351

H410

M = 10

M = 10

616-213-00-2

Mandipropamid (ISO); 2-(4-Chlorphenyl)-N-{2-[3-methoxy-4-(prop-2-yn-1-yloxy)phenyl]ethyl}-2-(prop-2-yn-1-yloxy)acetamid

—

374726-62-2

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

M = 1

M = 1

616-214-00-8

Metosulam (ISO); N-(2,6-Dichlor-3-methylphenyl)-5,7-dimethoxy[1,2,4]triazolo[1,5-a]pyrimidin-2-sulfonamid

—

139528-85-1

Carc. 2

STOT RE 2

Aquatic Acute 1

Aquatic Chronic 1

H351

H373 (Augen, Nieren)

H400

H410

GHS08

GHS09

Wng

H351

H373 (Augen, Nieren)

H410

M = 1 000

M = 100

616-215-00-3

Dimethenamid-P (ISO); 2-Chlor-N-(2,4-dimethyl-3-thienyl)-N-[(2S)-1-methoxypropan-2-yl]acetamid

—

163515-14-8

Acute Tox. 4

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H317

H400

H410

GHS07

GHS09

Wng

H302

H317

H410

M = 10

M = 10

616-216-00-9

Flonicamid (ISO); N-(Cyanomethyl)-4-(trifluormethyl)pyridin-3-carboxamid

—

158062-67-0

Acute Tox. 4

H302

GHS07

Wng

H302

616-217-00-4

Sulfoxaflor (ISO); [Methyl(oxo){1-[6-(trifluormethyl)-3-pyridyl]ethyl}-λ6-sulfanyliden]cyanamid

—

946578-00-3

Acute Tox. 4

Aquatic Acute 1

Aquatic Chronic 1

H302

H400

H410

GHS07

GHS09

Wng

H302

H410

M = 1

M = 1